Entities / Company
Vaxart.
American biotechnology company based in San Francisco
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
Gone quiet
No new reports in 90+ days-
MarketBeat provided average stock rating data for Vaxart stock on August 19, 2026.Some support2 reports
-
Vaxart is resolving a proxy contest concerning board appointments involving a stockholder group.Some support1 report
-
OTC Markets Group welcomed Vaxart to the OTCQX market on July 8, 2025.Speculative1 report
-
Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.Some support1 report
-
David Whitney is a concerned stockholder of Vaxart.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Vaxart this week
News at the entities that move Vaxart most-
MarketBeat Mentioned togetherMarketBeat used its stock screener tool to highlight Walmart.Moves Vaxart
Connections
The 6 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sean Tucker Structural
Sean Tucker serves as the Founder and Chief Scientific Officer of Vaxart.
-
Steven Lo Structural
Steven Lo serves as the Chief Executive Officer of Vaxart.
-
BARDA is conducting significant testing for Vaxart, indicating a formal dependency relationship.
-
Institutional Shareholder Services Structural
ISS provides proxy voting recommendations that influence Vaxart's corporate governance decisions.
-
MarketBeat Mentioned together
MarketBeat provides average rating data and stock coverage for Vaxart.
-
Sanofi Operational
Sanofi is considering opting into Vaxart's COVID-19 program.
History
Events by the month they beganAugust 2026
1 eventJuly 2026
1 eventJune 2026
4 events- Vaxart appointed Steven Lo as Chief Executive Officer and Michael J. Finney as Chairman of the Board on September 3, 2025.
- OTC Markets Group welcomed Vaxart to the OTCQX market on July 8, 2025.
- Vaxart was classified in the Zacks Medical - Drugs industry as of August 14, 2025.
- David Whitney is a concerned stockholder of Vaxart.